Skandinaviska Enskilda Banken (SEB)’s Surmodics SRDX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35,075	Closed	-$1.05M	–	817
2025 Q3	$1.05M	Sell	35,075 -39,935	-53%	-$1.33M	﹤0.01%	625
2025 Q2	$2.23M	Buy	75,010 +17,384	+30%	+$501K	0.01%	565
2025 Q1	$1.76M	Sell	57,626 -1	-0%	-$34	0.01%	591
2024 Q4	$2.28M	Buy	57,627 +7,279	+14%	+$283K	0.01%	546
2024 Q3	$1.95M	Buy	+50,348	New	+$2.04M	0.01%	591

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s SRDX Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 35,075 shares — an estimated $1.05M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $2.28M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Skandinaviska Enskilda Banken (SEB) reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 35,075 Surmodics shares in Q4 2025, an estimated $1.05M.
Skandinaviska Enskilda Banken (SEB) first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
Skandinaviska Enskilda Banken (SEB)'s Surmodics position peaked at $2.28M in Q4 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.